Â鶹AV

D2R Lunch & Learn with Illumina

Monday, June 10, 2024 11:00to14:00

Are you preparing an application for D2R | DNA to RNA funding programs? Join us, on June 10, from 11:00am to 2:00pm, for an in-person workshop to learn about the vast array of genomic solutions...

D2R Virtual Information Session

Wednesday, May 15, 2024 12:00to13:00

Join us for a virtual information session about D2R’s upcoming funding programs to be launched in May: Commercialization Priming and Major Partnerships....

Lecture by Professor Sir Paul Nurse on May 1, 2024

Published: 23 April 2024

As part of the Distinguished Professors Lecture Series by RI-MUHC, Professor Sir Paul Nurse, Chief Executive Officer of The Francis Crick Institute and Nobel Laureate in Physiology or Medicine will...

Professor Claude Bhérer and her team are studying the genomes of founder populations and their genetic diseases

Published: 22 April 2024

In a recent article published by the Â鶹AV Reporter, we learn about Claude Bhérer's journey from biological anthropology to population genetics. Following her nephew's sudden death from lactic...

A new network will advance research and care for thousands of people suffering from a rare or undiagnosed disease

Published: 22 April 2024

A new network will advance research and care for thousands of people suffering from a rare or undiagnosed disease. Read this article to learn how RARE.Qc, a network led by experts at the Research...

Dr. Sleiman and Prof. Damha receive CFI award for their work on Nucleic Acids for Precision Medicine

Published: 22 April 2024

Congratulations to D2R’s Associate Scientific Director, Hanadi Sleiman, and Professor Masad J. Damha on their recent award from the Canada Foundation for Innovation (CFI) for their groundbreaking...

Tokyo Symposium & Workshop on Genomic Medicine, Therapeutics and Health

Monday, April 8, 2024toSaturday, April 13, 2024

This symposium will bring academic and industry scientists together to discuss research at the frontiers of biomedical science and its interface with computational advances that will transform the...

Pages

Back to top